Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  


ASTRAZENECA PHARMA Gains 6%; BSE HEALTHCARE Index Up 0.9%
Tue, 12 Nov 10:56

ASTRAZENECA PHARMA Gains 6%; BSE HEALTHCARE Index Up 0.9%Image source: Chunumunu/www.istockphoto.com

ASTRAZENECA PHARMA share price has zoomed 6% and is presently trading at Rs 7,723.0.

Meanwhile, the BSE HEALTHCARE index is at 43,876.3 (up 0.9%).

Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 4.1%) and IPCA Labs (up 4.1%).

Dr. Reddys (down 0.7%) and Cipla (down 0.5%) are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 4,789.7 to Rs 7,723.0, registering a gain of Rs 2,933.3 (up 61.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,646.0 to 43,876.3, registering a gain of 53.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 208.5%), SUVEN PHARMACEUTICALS (up 121.5%) and Glenmark Pharma (up 107.4%).

For Investors: Our Big Prediction

What About the Benchmark Indices?

The BSE Sensex is at 79,480.9 .

The top losers among the BSE Sensex today are HDFC Bank (down 1.7%) and Asian Paints (down 1.4%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.

In the meantime, NSE Nifty is at 24,135.6 . HDFC Bank and Asian Paints are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,975.6 to 79,480.9, registering a gain of 14,505.3 points (up 22.3%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit fell 121.9% YoY to Rs -118 million for the quarter ended June 2024, compared to a profit of Rs 539 million a year ago. Net sales rose 31.2% to Rs 3,875 million during the period as against Rs 2,955 million in April-June 2023.

For the year ended March 2024, ASTRAZENECA PHARMA reported 62.7% increase in net profit to Rs 1,615 million compared to net profit of Rs 993 million during FY23. Revenue of the company grew 29.2% to Rs 12,955 million during FY24.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 201.4.


Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Gains 6%; BSE HEALTHCARE Index Up 0.9%". Click here!